Publication: Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening
dc.contributor.author | TÜRELİ, DERYA | |
dc.contributor.authors | Altas, Hilal; Tureli, Derya; Cengic, Ismet; Kucukkaya, Fikret; Aribal, Erkin; Kaya, Handan | |
dc.date.accessioned | 2022-03-12T20:28:57Z | |
dc.date.available | 2022-03-12T20:28:57Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background An important difficulty regarding the Breast Imaging Reporting and Data System (BI-RADS) category 3 assessment is the need for extensive diagnostic workup and an additional 6-month follow-up study. Purpose To evaluate the feasibility of the BI-RADS category 3 assessments at opportunistic screening. Material and Methods Mammography charts of 9062 screening patients in a major teaching hospital situated in an urban setting of a developing country were evaluated retrospectively (1997-2010). BI-RADS category 3 patients, called for a 6-month follow-up, which comprised a single-view spot or magnification mammogram. The length of follow-up period, compliance to periodic mammographic surveillance, cancer detection rate, and negative predictive values of category 3 assessments were calculated. Results Of the screened population, 9.2% were assigned BI-RADS category 3, and 31.2% of these cases were lost to follow-up. The mean follow-up period for 606 patients was 36.9 months. The negative predictive values for 6-month, 12-month, and final control studies were 90.9%, 87.5%, and 100%, respectively. Patient compliance for 6 months, 12 months, and any control evaluations beyond 12 months was low (50.0%, 29.8%, and 47.5%, respectively). Cancer detection rate was 0.8%. Conclusion Results of the study supports the feasibility of the BI-RADS category 3 assessments at opportunistic screening without any additional diagnostic workup. The practice of category 3 assessment following screening mammograms may be a more cost-effective method for developing countries with high recall rates and low resources in eliminating the maximum risk with minimum cost within the limits of available resources. | |
dc.identifier.doi | 10.1177/0284185115587733 | |
dc.identifier.eissn | 1600-0455 | |
dc.identifier.issn | 0284-1851 | |
dc.identifier.pubmed | 26019241 | |
dc.identifier.uri | https://hdl.handle.net/11424/234001 | |
dc.identifier.wos | WOS:000386008800006 | |
dc.language.iso | eng | |
dc.publisher | SAGE PUBLICATIONS LTD | |
dc.relation.ispartof | ACTA RADIOLOGICA | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Breast cancer | |
dc.subject | screening mammography | |
dc.subject | BI-RADS category 3 | |
dc.subject | short-interval follow-up | |
dc.subject | cancer detection rate | |
dc.subject | PROBABLY BENIGN LESIONS | |
dc.subject | MAMMOGRAPHIC FOLLOW-UP | |
dc.subject | AMERICAN-COLLEGE | |
dc.subject | PREDICTIVE-VALUE | |
dc.subject | BREAST | |
dc.subject | MANAGEMENT | |
dc.subject | RECOMMENDATION | |
dc.subject | PATIENT | |
dc.title | Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | 8ba0f597-2140-4137-82b4-21b1e7098a46 | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.indexed.at | PUBMED | |
local.journal.numberofpages | 6 | |
local.journal.quartile | Q2 | |
oaire.citation.endPage | 1309 | |
oaire.citation.issue | 11 | |
oaire.citation.startPage | 1304 | |
oaire.citation.title | ACTA RADIOLOGICA | |
oaire.citation.volume | 57 | |
relation.isAuthorOfPublication | 88507fe5-da7b-40c8-b5f7-83b63d66dae9 | |
relation.isAuthorOfPublication.latestForDiscovery | 88507fe5-da7b-40c8-b5f7-83b63d66dae9 |